| Serial Number | 99078272 |
| Word Mark | DIMDNA |
| Filing Date | Tuesday, March 11, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, January 6, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 6, 2026 |
| Goods and Services | Chemical preparations, enzymes and DNA for the preparation of nucleic acids for scientific and industrial purposes; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; linear nucleic acids for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; single stranded nucleic acids for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; single and double-stranded nucleic acids for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; aptamers for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific, industrial, and research use; DNA extracts being active chemical ingredients for use in the manufacture of therapeutics, biotechnology products and nanotechnology products; chemical preparations in the nature of DNA extracts for use in therapeutic, biotechnology and nanotechnology research |
| Goods and Services | Pharmaceutical preparations for the diagnosis and treatment of human and veterinary genetics disease and genetic diseases treatable with a nucleic acid therapy; pharmaceutical preparations for the prevention and treatment of genetic diseases; pharmaceutical preparations for human genetic medicines for treatment of genetic disease and genetic diseases treatable with a nucleic acid therapy; pharmaceutical preparations consisting of nucleic acid sequences, DNA extracts, and chemical reagents for medical use for treatment of genetic diseases and genetic diseases treatable with a nucleic acid therapy; therapeutic nucleic acid preparations for treatment of genetic diseases and genetic diseases treatable with a nucleic acid therapy; nucleic acid preparations having aptamers for medical or veterinary purposes; pharmaceutical preparations consisting of single stranded nucleic acids, DNA extracts and cassettes for treatment of genetic diseases and genetic diseases treatable with a nucleic acid therapy; pharmaceutical preparations consisting of single and double-stranded nucleic acids, DNA extracts and cassettes for treatment of genetic diseases and genetic diseases treatable with a nucleic acid therapy; pharmaceutical preparations consisting of linear nucleic acids, DNA extracts and cassettes for treatment of genetic diseases and genetic diseases treatable with a nucleic acid therapy; pharmaceutical preparations consisting of single and double-stranded nucleic acids, DNA extracts and cassettes for treatment of genetic diseases and genetic diseases treatable with a nucleic acid therapy; nucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labeling, imaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds |
| Goods and Services | Scientific and technological services, namely, research and design in the field of nucleic acid research and development; chemical and biological analysis and research services; scientific research in the field of nucleic acids; scientific research and development in the field of creation of DNA extracts; scientific research, analysis, design and development relating to DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of therapeutics, gene therapy, genetic medicines, diagnostics, biotechnology and nanotechnology; scientific research consultancy in the fields of therapeutics, gene therapy, genetic medicines, diagnostics, biotechnology, nanotechnology and DNA analysis |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 11, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 11, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 11, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SonoThera, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | SonoThera, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Tuesday, March 11, 2025 | NEW APPLICATION ENTERED |
| Tuesday, March 11, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 11, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, August 12, 2025 | ASSIGNED TO EXAMINER |
| Thursday, August 14, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, August 14, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, August 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 11, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 11, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 11, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 9, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, December 9, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 9, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, December 9, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, December 9, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 31, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 6, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 6, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |